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Abstract
Missense mutants in the late endosomal Rab7 GTPase cause the autosomal dominant peripheral neuropathy Charcot-Marie-
Tooth disease type 2B (CMT2B). As yet, the pathological mechanisms connecting mutant Rab7 protein expression to altered
neuronal function are undefined. Here, we analyze the effects Rab7 CMT2B mutants on nerve growth factor (NGF)
dependent intracellular signaling in PC12 cells. The nerve growth factor receptor TrkA interacted similarly with Rab7 wild-
type and CMT2B mutant proteins, but the mutant proteins significantly enhanced TrkA phosphorylation in response to brief
NGF stimulation. Two downstream signaling pathways (Erk1/2 and Akt) that are directly activated in response to phospho-
TrkA were differentially affected. Akt signaling, arising in response to activated TrkA at the plasma membrane was
unaffected. However Erk1/2 phosphorylation, triggered on signaling endosomes, was increased. Cytoplasmic phospho-Erk1/
2 persisted at elevated levels relative to control samples for up to 24 h following NGF stimulation. Nuclear shuttling of
phospho Erk1/2, which is required to induce MAPK phosphatase expression and down regulate signaling, was greatly
reduced by the Rab7 CMT2B mutants and explains the previously reported inhibition in PC12 neurite outgrowth. In
conclusion, the data demonstrate a mechanistic link between Rab7 CMT2B mutants and altered TrkA and Erk1/2 signaling
from endosomes.
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Introduction
Charcot-Marie-Tooth (CMT) disease is a family of inherited
disorders that usually results in the degeneration of peripheral
sensory and motor neurons [1–4]. Disease onset occurs in
adolescence or adulthood and is manifested by muscle weakness
and loss of fine motor control and sensation in the extremities. The
five disease subtypes include autosomal dominant, X-linked and
recessive forms that affect the function of Schwann cells and/or
neurons and fall into two general groups [2]. Type 1 subtypes
affect myelination or cell communication principally in Schwann
cells and include CMT1A-B, CMT3 (hypertrophic neuropathy of
Dejerine-Sottas), some forms of CMT4A, CMT4B and CMTX
[1]. Type 2 subtypes result in axonal degeneration and include
CMT2A-G, I-L, and intermediate CMT, DI-CMTB [4]. The
similarities in disease manifestation resulting from mutations in
over 20 known genes may be ascribed to the extensive
interdependence of Schwann cells and neurons, and to the fact
that the gene products are operative on common pathways. For
example, multiple CMT disease associated genes affect proteins
that regulate endocytic membrane transport and thereby impact
neurons and Schwann cells in the maintenance of axon viability.
Among the genes associated with CMT disease are those that
encode proteins involved in the regulation of endocytosis and
growth factor signaling, one of which is the Rab7 GTPase. Rab7
regulates transport of growth factors and other cargo from early to
late endosomes and on to lysosomes by controlling membrane
budding, cytoskeletal transport and fusion between endocytic
compartments. Following nerve growth factor (NGF) stimulation
of neurons, Rab7 forms a transient complex with the internalized
NGF receptor called TrkA and thereby impacts receptor signaling
and neurite outgrowth [5–9]. Expression of dominant negative
Rab7 prolongs TrkA signaling, increases the activation of
downstream Erk1/2 and alters neurite outgrowth [9]. Similarly,
ectopic expression of the Rab7 CMT mutants leads to an
inhibition of neurite outgrowth in PC12 cells [10]. Given the
close association between Rab7 and TrkA in regulating neurite
outgrowth, it remains to be clarified how the CMT disease
mutants affect the interaction and activation of TrkA. To better
understand the underlying mechanisms of CMT it is also of
interest to define the impact of these mutations.
There are four mutations in the Rab7 gene that have been
identified as disease-causal in CMT2B patients [11–13]. All four
are missense mutations that change residues L129F, K157N,
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Interestingly, however these mutations alter highly conserved
amino acids present in all Rab GTPases, suggesting that they are
critical to the function of these small GTPases. In contrast, point
mutations in or near the nucleotide binding pocket of Rab7 have
been well-characterized and have been shown to preferentially
stabilize Rab7 in the active (GTP-bound, Rab7Q67L) or inactive
(GDP-bound, Rab7T22N) states. In particular, inactivating
mutants have significant effect on endocytic trafficking and
signaling [5–7,9,14,15]. While the Rab7 CMT2B mutants do
retain GTP-binding activity they exhibit dysregulated nucleotide
binding in vitro [16,17]. This effect on nucleotide binding is
thought to result in increased retention of mutant protein on target
membranes leading to the enhanced interaction with a subset of
effector proteins [16]. Interestingly however it has been reported
that the binding to the effector protein, RILP, that regulates
retrograde trafficking of TrkA positive endosomes to the cell body
was unaffected by these mutations [17], yet neurite outgrowth was
altered [10]. Because the fidelity of endocytic transport from
internalization to lysosome delivery and proper coupling to
signaling pathways plays a pivotal role in the maintenance of
myelination and axonal function of sensory and motor neurons it
becomes important to understand the mechanistic details of how
the disease specific mutations alter intracellular signaling.
In the present study, we demonstrate that the Rab7 CMT2B
mutants increase endosomal TrkA signaling leading to enhanced
Erk signaling. The activated Erk proteins predominate in the
cytoplasm in lieu of their normal nuclear localization following
NGF stimulation of TrkA. These observations provide new insight
into the molecular basis for the alterations in neurite outgrowth
and axonal viability associated with the CMT disease state.
Results
The CMT2B-associated Rab7 mutants interact with TrkA
The interaction of Rab7 with the receptor tyrosine kinase
(RTK), TrkA is NGF dependent and furthermore the association
is time dependent following nerve growth factor (NGF) stimulation
[9]. To study the impact of the CMT2B associated Rab7 mutants
on TrkA interaction, we generated the GFP-tagged versions of
Rab7 bearing L129F, K157N, N161T and V162M substitutions.
Based on our previous studies, GFP-Rab7 fusion proteins preserve
the functional properties of the untagged proteins [14]. As shown
in Figure 1A, all of the CMT2B associated Rab7 mutants were
observed to accumulate with a perinuclear distribution consistent
with localization to endosomes. The level of expression of GFP-
tagged Rab7 wt and mutant proteins in transfected PC12 cells was
,3-fold higher than the endogenous Rab7 with transfection
Figure 1. Rab7 CMT2B Mutants are Membrane Bound and Interact with TrkA. (A) BHK cells were transfected with GFP-tagged Rab7 wild-
type and CMT2B disease mutants. After 16 h of transfection, cells were fixed and permeabilized by saponin treatment. Enlarged perinuclear vesicular
staining was observed for the CMT2B disease mutants. (B) PC12 cells were stimulated with NGF (200 ng/ml) for 15–60 min as indicated. Cells were
lysed and samples of cell lysates were immunoblotted for TrkA and Rab7. Lysate samples containing equal amounts of protein were
immunoprecipitated (IP) with a pAb directed against Rab7 and immunoblotted for TrkA. Subsequently, the membrane was stripped and reprobed for
Rab7. (C) PC12 cells were transfected with wild-type GFP-Rab7 and stimulated with NGF for 60 min. Samples containing equal amounts of protein
were immunoprecipitated with antibodies against GFP to isolate the GFP-Rab7 and subsequently immunoblotted for TrkA. The membrane was
stripped and reprobed with antibodies against GFP. (D) PC12 cells were transfected with GFP-tagged Rab7 CMT2B disease mutants and stimulated
with NGF for 60 min. Equal amounts of lysate samples were immunoprecipitated with antibodies against GFP to precipitate the GFP-Rab7 and
subsequently immunoblotted for TrkA. The membrane was stripped and reprobed with antibodies against GFP. (B–D) Representative blots from one
of three independent experiments are shown in each case.
doi:10.1371/journal.pone.0015351.g001
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published literature [9], endogenous Rab7 was found to co-
immunoprecipitate with TrkA following NGF stimulation and the
maximum interaction occurred 1 h after stimulation (Figure 1B).
Therefore, we used 1 h NGF stimulation to test for an interaction
between TrkA and GFP-tagged wild-type Rab7 as well as the
CMT2B GFP-Rab7 mutants. GFP-tagged wild-type Rab7 and the
Rab7 CMT2B mutants were all seen to co-immunoprecipitate with
TrkA at similar levels (Figure 1C-1D), indicating that the mutant
proteins were not impaired in their ability to bind to TrkA receptor.
Rab7 CMT2B mutants expressing PC12 cells show
differential TrkA phosphorylation following NGF
stimulation
Rab7 is known to control endosomal trafficking of TrkA as well
as receptor signaling. To assess the effect of the Rab7 CMT
mutants on NGF signaling, PC12 cells expressing the mutant
proteins were briefly stimulated with NGF followed by removal of
residual surface bound NGF (‘surface stripping of ligand’ as
described in Materials and Methods) to maximize detection of
signaling from activated, internalized TrkA receptors over the
course of 2–24 h. Higher phospho-TrkA levels were consistently
observed across multiple time points in cells expressing the GFP-
Rab7 CMT mutants as compared to GFP-Rab7 wild-type or GFP
only expressing control cells (Figure 2A). Expression levels of all
GFP proteins were constant at all time points. Quantification of
replicate experiments showed that Rab7L129F, Rab7K157N,
Rab7N161T and Rab7V162M expressing cells had 2.1–3.9 fold
higher levels of phospho-TrkA than the GFP only expressing
control cells and 1.3–1.8 fold higher levels than the GFP-Rab7
wild-type expressing cells at the 2 h and 6 h time points (Figure 2B,
numerical values are provided in Table 1). At the 24 h time points,
the pTrkA signal was greatly diminished and the differences
between the mutants and the controls were no longer statistically
significant. There was no down regulation of total TrkA levels in
the lysates, similar to previous reports where Rab7 dominant
negative mutant was expressed [9]. Nevertheless, the higher TrkA
phosphorylation is suggestive of differential interaction of the
Rab7 mutants with signaling complexes that leads to an increase in
activated TrkA receptors in endosomes.
Rab7 CMT2B mutants expressing PC12 cells show
enhanced ERK signaling on NGF stimulation
Upon NGF stimulation, PC12 cells stop proliferating and start
differentiating [18]. NGF-mediated TrkA signaling in PC12 cells
typically activates Erk1/2 and Akt downstream signaling. The Erk
activation module is located on endosomes [19–21] and is
instrumental in NGF stimulated differentiation signaling from
TrkA containing endosomes [22]. To investigate the activation of
these signaling mediators, PC12 cells transiently expressing Rab7
CMT2B mutants were briefly stimulated with NGF followed by
surface stripping of ligand. Compared to control cells expressing
GFP only or GFP-Rab7 wild-type protein, PC12 cells expressing
the GFP-Rab7 CMT2B mutants consistently showed 1.5–2.2 fold
higher levels of phosphorylated Erk1/2 at all time points examined
(Figure 3A–3B, numerical values are provided in Table 1),
providing evidence for enhanced downstream signaling.
Rab7 CMT2B mutants expressing PC12 cells show no
significant changes in Akt phosphorylation on NGF
stimulation
The effect of NGF stimulation on the second major downstream
signaling pathway regulated by phosphorylation of Akt was also
analyzed in PC12 cells transiently expressing the Rab7 CMT2B
mutants. There was no significant change in the Akt phosphor-
ylation levels in the cells expressing the disease mutants when
compared to cells expressing GFP alone or GFP-Rab7 (Figure 4A–
4B). The activation of Akt was similar in all samples at early time
points and diminished uniformly at 24 h. The findings are in
agreement with a previous observation indicating that NGF-
stimulated Akt signaling occurs at the cell surface and is not
triggered on the endosomes [21]. The combined data suggest that
alterations in TrkA downstream signaling are confined to
endosomes and the Erk module, and are independent of Akt.
Rab7 CMT2B mutants expressing PC12 cells show altered
subcellular localization of phosphorylated Erk1/2 on NGF
stimulation
To examine the subcellular distribution of activated Erk1/2 on
NGF stimulation in PC12 cells we used subcellular fractionation to
separate the cytosolic and nuclear fractions. Probing with lamin B,
a nuclear envelope protein, tested the purity of the fractions.
Following brief NGF stimulation and surface stripping of ligand,
cells expressing the Rab7 CMT2B mutants were reincubated in
starvation medium for 2 h and 24 h. At the shorter time point, the
Rab7 CMT2B mutant expressing cells showed diminished levels of
the activated Erk1/2 in the nucleus compared to GFP expressing
control cells and consequently predominant cytoplasmic distribu-
tion of activated Erk1/2 (Figure 5A). However, after a 24 h post-
stimulation chase period, activated Erk1/2 was no longer detected
in the nuclear fraction in either the CMT Rab7 mutant or the
wild-type Rab7 expressing cells (Figure 5B). Interestingly, the level
of phosphorylated Erk1/2 remained higher in the cytosolic
fraction of the disease mutants relative to cells expressing the
wild-type Rab7, suggesting either enhanced phosphorylation or
decreased dephosphorylation of the Erk1/2 in the cells expressing
the disease mutants.
Discussion
Charcot Marie Tooth Type 2B disease involves mutations in
conserved amino acid residues of the late endocytic regulator
Rab7. The four missense mutations of Rab7 implicated in the
disease show similar biochemical properties that have been
associated with the proteins being predominantly in GTP bound
state [17,23]. Here we demonstrate that the Rab7 CMT2B
mutants enhance Erk signaling. This enhanced Erk signaling is
likely to be dependent on the endosomal membrane residence
time of the activated TrkA, which is in turn regulated by Rab7.
Being predominantly in the GTP bound state the Rab7 CMT2B
mutants would be expected to promote premature degradation of
the TrkA containing signaling endosomes. However, it has been
suggested that increased interaction of the CMT2B associated
Rab7 mutants with various effector proteins notably Vps13C and
ORP1L might result in an increase in the fraction of Rab7
CMT2B mutants that is active, but slow the transport of signaling
endosomes and/or fusion with lysosomes by reducing temporal
progression [16]. Consequently, the net effect of slowed trafficking
of the activated TrkA caused by Rab7 CMT2B mutants present
on endosomes is entirely consistent with the observed enhance-
ment of phosphorylated Erk1/2 in PC12 cells.
Brief stimulation of PC12 cells expressing the disease causing Rab7
CMT2B mutants with NGF did not significantly affect Akt
phosphorylation. There have been reports of the presence of activated
Akt in various cell organelles such as nucleus, Golgi apparatus, cell
surface and mitochondria, although not endosomes [24,25]. There-
fore, consistent with previous work showing Akt signaling predomi-
CMT2B Alters NGF-Stimulated Signaling
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does not emanate from endosomes containing activated TrkA.
The strong persistence of phosphorylated Erk1/2 24 h after
brief NGF stimulation was reported previously in PC12 cells
expressing the GDP-bound Rab7T22N mutant [9]. The expres-
sion of the Rab7T22N mutant, which is stabilized in inactive state,
did not however preclude nuclear localization of the activated
Erk1/2. Furthermore, inhibition of Rab7 activity by overexpress-
ing the Rab7T22N was shown to trigger neurite outgrowth in
PC12 cells following brief NGF stimulation [9]. In contrast, we
demonstrate that the Rab7 mutants associated with CMT2B led to
accumulation of the phosphorylated Erk1/2 in the cytosol rather
than the nucleus. This may explain the inhibitory effect of the
Rab7 CMT2B mutants on neurite outgrowth as recently observed
[10]. Sensory neurons have very long axons and endocytosis
typically occurs at the distal axonal terminal. Signaling endosomes
must therefore traverse a long way to the cell body via retrograde
transport and consequently misregulation of the Rab7 cycle under
diseased conditions (e.g. mutant versions of Rab7) would lead to
altered trafficking and deficits in the translocation of activated
Figure 2. Cells Expressing Rab7 CMT2B Mutants Exhibit Higher Levels of Phospho-TrkA Following NGF Stimulation. (A) Transiently
transfected PC12 cells expressing GFP, GFP-Rab7wt, GFP-Rab7L129F, GFP-Rab7K157N, GFP-Rab7N161T, GFP-Rab7 V162M were briefly stimulated with
NGF (200 ng/ml) followed by surface stripping of ligand and reincubation in 0.1% BSA-DMEM for 2 h, 6 h and 24 h respectively. Subsequently, cells
were lysed and equal amounts of protein were immunoblotted and probed for total and phosphorylated TrkA. Significantly, higher levels of
phosphorylated TrkA were found at 2 h and 6 h. Equal amounts of protein from cell lysates were probed with antibodies against GFP. GFP-Rab7wt
and GFP-Rab7 CMT2B mutant proteins are uniformly expressed in PC12 cells under these conditions as shown in the adjacent representative blot. (B)
Films from four independent experiments were quantified by Image J analysis. Bar graphs show pTrkA in GFP-Rab7wt and CMT2B mutant expressing
cells. In each case the amount of pTrkA was normalized to the amount of GFP protein expressed. The bar graph shows the fold-change in pTrkA as a
function of pTrkA in the GFP only control at each respective time point. Error bars indicating mean6S.E.M., n=4, **p,0.01, ***p,0.001. For detailed
numerical values see Table 1.
doi:10.1371/journal.pone.0015351.g002
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these mutants in cells bearing longer neurites (.50 mm) [10]. The
accumulation of activated Erk1/2 in the cytoplasm suggests that
the CMT2B associated mutants retard kinase shuttling to the
nucleus, which is required to upregulate the genes responsible for
differentiation of sensory neurons. The data shed new light on the
mechanism mediating the deficits in neurite outgrowth in Charcot-
Marie-Tooth disease.
An intriguing question that remains is the role played by the
MAP kinase phosphatases (MKPs) in regulating the level of
phosphorylated Erk1/2. MKP3 expression is triggered by the
translocation of the activated Erk to the nucleus, is maximal
around 3 h after NGF stimulation and the upregulation can last as
long as five days in PC12 cells [26]. MKP3 is cytoplasmic and acts
specifically on Erk [27]. Because the disease associated Rab7
CMT2B mutants lead to a significantly higher levels of activated
Erk1/2, the negative regulatory function that is normally met
through the MKP activity is likely compromised in CMT2B
disease. Our results suggest that the impaired neurite growth,
which is an important disease phenotype, may be due in part to
retardation of shuttling of the phosphorylated Erk1/2 to the
nucleus, which is normally a prerequisite for upregulation of
MKP3 expression and down regulation of Erk signaling [18].
In conclusion, our study throws light on the pathogenic
mechanism leading to Charcot Marie Tooth Type2B disease by
defining the enhanced Rab7-dependent activation of TrkA and
downstream Erk signaling pathways.
Materials and Methods
Cells and reagents
PC12 and BHK-21 cells were from American Type Culture
Collection (Manassas, VA). PC12 cells were grown in DMEM
supplemented with 10% horse serum, 2.5% FBS, 2 mM
glutamine, 50 U/ml penicillin and 50 mg/ml streptomycin and
BHK-21 were grown in complete G-MEM (10% fetal calf serum,
2 mM glutamine, 50 U/ml penicillin, 50 mg/ml streptomycin,
and 2.6 mg/ml tryptose phosphate broth). Cell culture reagents
were purchased from Invitrogen/Gibco (Carlsbad, CA). Restric-
tion and modification enzymes were from New England Biolabs
(Ipswich, MA) and all chemicals used were from Sigma-Aldrich
(St. Louis, MO). Recombinant NGF was from Invitrogen.
Mutagenesis and plasmid construction
Rab7a used in these studies was Canis lupus familiaris
(NM_001003316) [28]. GFP-tagged Rab7 CMT2B mutants
(L129F, K157N, N161T and V162M) were constructed by site
directed mutagenesis of wild-type GFP-Rab7 in the pEGFP-C3
vector. The plasmids were used as templates for PCR-based
mutagenesis. All amino acid substitutions were generated by a
one-step reverse cyclic PCR method using the appropriate base
changes in the synthetic oligonucleotides [29]. The primer
sequences used for generating the mutants were as follows:
Rab7L129F (Fwd-59-ATTGACTTCGAAAACAGACAAGTG-
GC-39,R e v - 5 9-CTTGTTTCCCAACACAACGAAAGGGA-39),
Rab7K157N (Fwd-59AGTGCCAACGAGGCCATCAATGT-
GG-39, Rev-59-GGTCTCGAAGTAGGGAATGTTGTTT-39),
Rab7N161T (Fwd -59-GCCATCACCGTGGAGCAGGCGT-
TCCA-39, Rev -59-CTCCTTGGCACTGGTCTCGAAGTAG-
G-39 and
Rab7V162M (Fwd -59GCCATCAATATGGAGCAGGCGT-
TCCA-39 and Rev -59-CTCCTTGGCACTGGTCTCGAAG-
TAGG-39). Mutations were confirmed by sequencing the entire
Rab7 gene.
Transient Transfection and Expression of Rab7 CMT2B
Mutants
Cell lines were cultured as described above and passaged on
consecutive days to maintain in logarithmic growth phase
immediately prior to transfection. Transfections of PC12 cells
were performed using Lipofectamine 2000 (Invitrogen) according
to manufacturer’s instructions. Rab7 expression was maximal 16–
24 h post-transfection and experiments were conducted during
this time frame. Transfection efficiency of ,35% was consistently
observed.
NGF stimulation protocol
NGF (200 ng/ml) stimulation was performed as described
previously [9].
Antibodies
Rabbit polyclonal antibody directed against Rab7 was used for
immunoblotting, and immunoprecipitation assays as described
[7,30–32]. The following commercial antibodies were used: mouse
Table 1. Fold-changes in phospho-TrkA and phospho- Erk1/2 due to Rab7 CMT2B mutants.
Expressed Protein
Phospho-TrkA
Fold change relative
to GFP
Phospho-TrkA
Fold change relative
to GFP-Rab7wt
Phospho-Erk1/2
Fold change relative
to GFP
Phospho-Erk1/2
Fold change relative
to GFP-Rab7wt
2h 6h 2 4h 2h 6h 2 4h 2h 6h 2 4h 2h 6h 2 4h
GFP 1.0 1.0 1.0 1.0 1.0 1.0
GFP-Rab7 wt 1.0 1.0 1.0 1.0 1.0 1.0
GFP-Rab7L129F 3.1
p,0.001
2.72
p,0.01
1.34
p,0.05
1.48
p,0.05
2.58
p,0.001
2.15
p,0.01
2.67
p,0.05
1.62
p,0.01
1.75
p,0.01
2.17
p,0.05
GFP-Rab7K157N 3.57
p,0.001
2.14
p,0.001
1.53
p,0.01
1.52
p,0.05
2.49
p,0.001
2.14
p,0.001
2.84
p,0.05
1.57
p,0.001
1.74
p,0.01
2.3
p,0.05
GFP-Rab7N161T 4.39
p,0.001
2.9
p,0.001
1.88
p,0.001
1.58
p,0.01
2.98
p,0.001
1.82
p,0.01
2.54
p,0.05
1.87
p,0.01
1.48
p,0.01
2.06
p,0.05
GFP-Rab7V162M 3.96
p,0.001
3.37
p,0.001
1.70
p,0.001
1.83
p,0.001
3.14
p,0.001
2.6
p,0.001
2.65
p,0.05
1.97
p,0.001
2.12
p,0.001
2.15
p,0.05
Data from 4 independent experiments measuring TrkA phosphorylation and 3 independent experiments assessing Erk1/2 phosphorylation were evaluated using
unpaired, one-tailed Student’s t-test.
doi:10.1371/journal.pone.0015351.t001
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phospho ERK1/2, rabbit pAb directed against phospho TrkA,
rabbit pAb directed against Akt, mouse mAb directed against
phospho Akt, b-actin rabbit mAb HRP conjugate, all from Cell
Signaling Technologies (Beverly, MA); rabbit pAb directed against
GFP from Invitrogen (Carlsbad, CA), mouse mAb directed against
Rab7 from Sigma, goat pAb directed against lamin B from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA), rabbit pAb directed
against TrkA from Millipore Inc. (Billerica, MA)
Immunoprecipitations
Sixteen hours (h) post-transfection, PC12 cells were washed in
PBS and transferred to DMEM/BSA, starved for 5 h and
stimulated with NGF for 10 min, followed by surface stripping
Figure 3. Cells Expressing Rab7 CMT2B Mutants Exhibit
Enhanced Erk Signaling Following NGF Stimulation. (A) Tran-
siently transfected PC12 cells expressing GFP, GFP-Rab7wt, GFP-
Rab7L129F, GFP-Rab7K157N, GFP-Rab7N161T, GFP-Rab7 V162M were
briefly stimulated with NGF (200 ng/ml) followed by surface stripping of
ligand and reincubation in 0.1% BSA-DMEM for 2–24 h. Subsequently,
cells were lysed and equal amounts of protein were immunoblotted
and probed for total and phosphorylated Erk1/2. (B) Films from three
independent experiments were quantified by Image J analysis. Bar
graph shows levels of pErk1/2 in GFP-Rab7wt and CMT2B mutant
expressing cells. In each case the amount of pErk1/2 was normalized to
the amount of GFP protein expressed. The bar graph shows the fold-
change in pErk1/2 as a function of pErk1/2 in the GFP only control at
each respective time point. Error bars indicating mean6S.E.M.,
n=3,*p,0.05; **p,0.01, ***p,0.001. For detailed numerical values
see Table 1.
doi:10.1371/journal.pone.0015351.g003
Figure 4. Cells Expressing Rab7 CMT2B Mutants Have no Effect
on Akt Signaling. (A) Transiently transfected PC12 cells expressing
GFP, GFP-Rab7wt, GFP-Rab7L129F, GFP-Rab7K157N, GFP-Rab7N161T,
GFP-Rab7 V162M were briefly stimulated with NGF (200 ng/ml)
followed by surface stripping of ligand and reincubation in 0.1% BSA-
DMEM for 2–24 h. Subsequently, cells were lysed and equal amounts of
protein were immunoblotted and probed for total and phosphorylated
Akt. (B) Films from three independent experiments were quantified by
Image J analysis. Bar graph shows levels of pAkt in GFP-Rab7wt and
CMT2B mutant expressing cells. In each case the amount of pAkt was
normalized to the amount of GFP protein expressed. The bar graph
shows the fold-change in pAkt as a function of pAkt in the GFP only
control at each respective time point. Error bars indicating mean6S.E.M.
n=3, p values were not significant, indicating no differences between
samples.
doi:10.1371/journal.pone.0015351.g004
CMT2B Alters NGF-Stimulated Signaling
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15351of ligand with ice cold stripping buffer (0.2 M acetic acid and
0.5 M NaCl) [33]. Cells were subsequently washed thrice in ice
cold PBS and reincubated in serum free medium for the various
times (2–24 h). Cells were washed in PBS and lysed for 15 min on
ice in lysis buffer (0.5% NP40, 25 mM Tris-HCl, 100 mM NaCl,
50 mM NaF, 1 mM Na3VO4, pH 7.5 supplemented with protease
inhibitor mixture from Calbiochem/EMD Chemicals, Gibbstown,
NJ). Lysates were precleared by centrifugation at 13,000 rpm in an
Eppendorf microcentrifuge for 10 min and pretreatment with
protein A Sepharose (Amersham Biosciences/GE Healthcare,
Piscataway, NJ); 500 mg cell lysate/40 ml protein A Sepharose at
4uC for 3 h with mild rotation. The supernatant (precleared lysate)
was transferred in a clean microfuge tube and incubated with 3 mg
rabbit pAb directed against GFP (Invitrogen) for 2 h at 4uC.
Antibody complexes were recovered by incubation with protein A
Sepharose (40 ml) at 4uC for 3 h. Immunoprecipitates were
washed in 0.1% NP-40, 25 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 1 mM Na3VO4 supplemented with protease inhibitor and a
final wash of ice cold, 10 mM Tris-HCl, and pH 7.5. The beads
were boiled in Laemmli buffer and the proteins resolved by SDS-
PAGE (10% gel).
Subcellular Fractionation
Nuclear and cytosolic fractions were prepared as previously
described with minor modifications [34]. PC12 cells were plated
on 60 mm dishes and transfected to express the respective GFP-
tagged Rab7 wild-type or CMT disease mutants. To separate the
nuclear and cytosolic pools of Erk1/2, the cells were serum starved
for 5 h and stimulated with NGF for 10 min followed by surface
stripping of the ligand. The cells were then incubated in starvation
medium (DMEM containing 0.1% BSA) for 2 h, 6 h or 24 h at
37uC. The cells were washed thrice in ice cold PBS and scraped in
750 ml of lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl,
3 mM MgCl2 0.3% (v/v) NP-40, 1 mM PMSF, 1 mM Na3VO4,
Figure 5. Cells Expressing Rab7 CMT2B Mutants Exhibit Altered Cytoplasmic and Nuclear Partitioning of Activated Erk1/2.
Transiently transfected PC12 cells expressing GFP, GFP-Rab7wt, GFP-Rab7L129F, GFP-Rab7K157N, GFP-Rab7N161T, GFP-Rab7 V162M were briefly
stimulated with NGF (200 ng/ml) followed by surface stripping of ligand and reincubation in 0.1% BSA-DMEM for (A) 2 h and (B) 24 h. Subsequently,
cells were lysed and subjected to subcellular fractionation and immunoblotted with antibodies directed against phosphorylated Erk1/2. The purity of
fractions was confirmed by probing for the nuclear marker lamin B.
doi:10.1371/journal.pone.0015351.g005
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chymostatin, 10 mg/ml leupeptin, 10 mg/ml antipain and 10 mg/
ml pepstatin). Cells were incubated on ice for 5 min followed by
centrifugation at 5006g for 5 min to pellet the nuclei. The
cytosolic fraction separated in the supernatant. Nuclei pellets were
washed in the same lysis buffer without NP40. The cytosolic and
nuclear fractions were boiled in 26 Laemmli sample buffer and
resolved on a 10% SDS polyacrylamide gel and probed with a
phospho Erk1/2 antibody. The purity of the nuclear fraction was
checked with an antibody directed against nuclear lamin B.
Confocal Immunofluorescence microscopy
BHK21 cells were grown and processed for immunofluores-
cence staining using standard procedures. Briefly, transfected cells
overexpressing Rab7 GFP and the Rab7 CMT2B mutants GFP
were pre-permeabilized with 0.05% (v/v) saponin in PIPES buffer
(80 mM PIPES-KOH, pH 6.8, 5 mM EGTA, 1 mM MgCl2) for
2–3 min, to allow optimal visualization of membrane structures
and minimize cytosolic protein staining, and then fixed with 3%
(w/v) paraformaldehyde in PBS. The coverslips were washed four
times with PBS/saponin and mounted on glass slides in Mowiol 4–
88 [32]. Fixed cells were imaged on a Zeiss LSM510 confocal
microscope equipped with a 636oil immersion lens.
Statistical Analyses
The experiments were performed at least three times and
statistical data are shown as mean6S.E.M. Differences were
analyzed by unpaired, one-tailed Student’s t test using GraphPad
Prism software.
Supporting Information
Figure S1 GFP-Rab7wt and Rab7 CMT2B Mutant
Proteins are Uniformly Expressed in PC12 Cells 3-Fold
above Endogenous Levels. (A) Transiently transfected PC12
cells expressing GFP, GFP-Rab7wt, GFP-Rab7L129F, GFP-
Rab7K157N, GFP-Rab7N161T and GFP-Rab7 V162M were
lysed 16 h post-transfection and immunoblotted for Rab7 to probe
for GFP tagged proteins as well as the endogenous Rab7 levels. (B)
Films from three independent experiments were quantified using
Image J analysis. Values of overexpressed (OE) GFP-Rab7wt and
GFP-Rab7 CMT2B mutant protein expression were compared to
endogenous (Endo.) Rab7levels. Error bars indicating mean
6S.E.M. n=3, *p,0.05; **p,0.01.
Found at: doi: (TIF)
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